# US 2022/0032065 A1 · Devices and methods for sensing physiological signals during stimulation therapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0032065 A1
- Document ID: US20220032065A1
- Status: Published application
- Kind: A1
- Application number: 17/501,732
- Filed: 2021-10-14
- Published: 2022-02-03
- Earliest claimed: 2017-02-28
- Assignees: Medtronic, Inc.
- Applicants: Medtronic, Inc.
- Inventors: Scott Stanslaski; Robert Devine; Timothy Denison; Vincent Roczniak; Todd Smith; Thomas Adamski
- Web page: https://patentgrep.com/patent/US20220032065A1

## CPC

- A61N 1/36139: {with automatic adjustment}
- A61N 1/0529: {Electrodes for brain stimulation}
- A61N 1/0534: {Electrodes for deep brain stimulation}
- A61N 1/0553: {Paddle shaped electrodes, e.g. for laminotomy}
- A61N 1/3615: {Intensity}
- A61N 1/36178: {Burst or pulse train parameters}
- A61N 1/378: Electrical supply
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Devices and methods provide for the sensing of physiological signals by providing a stimulation waveform that includes a stimulation pulse followed by an active recharge pulse to clear the charge in capacitors within the stimulation path. The active recharge pulse is followed by a period of passive recharge and then a period of no recharge. Non-neurological sources of artifacts within the sensed physiological signal may be handled by providing a brief period of passive recharge followed by a lengthy period of no recharge, which is made possible by the use of the active recharge pulse prior to the passive recharge. The period of no recharge removes any low impedance path to ground from the stimulation electrodes, which allows an amplifier of the sensing circuit to provide common mode rejection of non-neurological signals, such as cardiac signals, present at the sensing electrodes.

## Claims

### Claim 1

A method of setting an active recharge ratio of an implantable stimulation device, comprising:
repeatedly providing from the implantable medical device stimulation waveforms that include a stimulation pulse followed by an active recharge pulse where each stimulation waveform utilizes a different active recharge ratio from other stimulation waveforms being provided where the active recharge ratio is based on an active recharge pulse amplitude relative to a baseline active recharge pulse amplitude;
sensing at the implantable medical device a sensed signal at a time between each of the stimulation waveforms being provided;
determining a peak-to-peak amplitude for each sensed signal;
selecting the active recharge ratio of the stimulation waveform that immediately preceded the sensed signal with the smallest peak-to-peak amplitude; and
using the selected active recharge ratio in subsequent stimulation waveforms provided by the implantable medical device.

### Claim 2 (depends on 1)

The method of claim 1, wherein the baseline active recharge pulse amplitude corresponds to an amplitude of the stimulation pulse.

### Claim 3 (depends on 1)

The method of claim 1, wherein the active recharge ratios comprise 0.8, 0.9, 1, 1.1, and 1.2.

### Claim 4 (depends on 1)

The method of claim 1, further comprising after using the selected active recharge ratio in subsequent stimulation waveforms, receiving a trigger at the implantable medical device and again repeatedly providing the stimulation waveforms utilizing different active recharge ratios, again sensing at the implantable medical device the sensed signal between the stimulation waveforms, again determining the peak-to-peak amplitude for each sensed signal, again selecting the active recharge ratio that immediately preceded the sensed signal with the smallest peak-to-peak amplitude, and again using the selected active recharge ratio in subsequent stimulation waveforms provided by the implantable medical device.

### Claim 5 (depends on 4)

The method of claim 4, wherein the trigger is new stimulation waveform programming.

### Claim 6 (depends on 4)

The method of claim 4, wherein the trigger is reaching a set amount of time.

### Claim 7 (depends on 1)

The method of claim 1, wherein sensing a sensed signal comprises producing a differential signal while applying common mode rejection.

### Claim 8 (depends on 1)

The method of claim 1, wherein the stimulation waveform also includes a period of passive recharge following the active recharge pulse.

### Claim 9 (depends on 8)

The method of claim 8, wherein the stimulation waveform also includes a period of no recharge following the passive recharge.

### Claim 10

An implantable medical device, comprising:
a stimulation engine that can produce a stimulation waveform including a stimulation pulse and an active recharge pulse;
a sensing circuit that can obtain a sensed signal;
a controller that is coupled to the stimulation engine and the sensing circuit, the controller being configured to:
cause the stimulation engine to repeatedly provide stimulation waveforms that include a stimulation pulse followed by an active recharge pulse where each stimulation waveform utilizes a different active recharge ratio from other stimulation waveforms being provided where the active recharge ratio is based on an active recharge pulse amplitude relative to a baseline active recharge pulse amplitude;
cause the sensing circuit to sense a sensed signal at a time between each of the stimulation waveforms being provided;
determine a peak-to-peak amplitude for each sensed signal;
select the active recharge ratio of the stimulation waveform that immediately preceded the sensed signal with the smallest peak-to-peak amplitude; and
cause the stimulation engine to use the selected active recharge ratio in subsequent stimulation waveforms.

### Claim 11 (depends on 10)

The implantable medical device of claim 10, wherein the baseline active recharge pulse amplitude corresponds to an amplitude of the stimulation pulse.

### Claim 12 (depends on 10)

The implantable medical device of claim 10, wherein the active recharge ratios comprise 0.8, 0.9, 1, 1.1, and 1.2.

### Claim 13 (depends on 10)

The implantable medical device of claim 10, wherein the controller is further configured to, after using the selected active recharge ratio in subsequent stimulation waveforms, receive a trigger and again cause the stimulation engine to repeatedly provide the stimulation waveforms utilizing different active recharge ratios, again cause the sensing circuit to sense the sensed signal between the stimulation waveforms, again determine the peak-to-peak amplitude for each sensed signal, again select the active recharge ratio that immediately preceded the sensed signal with the smallest peak-to-peak amplitude, and again cause the stimulation engine to use the selected active recharge ratio in subsequent stimulation waveforms.

### Claim 14 (depends on 13)

The implantable medical device of claim 13, wherein the trigger is new stimulation waveform programming.

### Claim 15 (depends on 13)

The implantable medical device of claim 13, wherein the trigger is reaching a set amount of time.

### Claim 16 (depends on 10)

The implantable medical device of claim 10, wherein the sensing circuit senses a sensed signal by producing a differential signal while applying common mode rejection.

### Claim 17 (depends on 10)

The implantable medical device of claim 10, wherein the stimulation waveform also includes a period of passive recharge following the active recharge pulse.

### Claim 18 (depends on 17)

The implantable medical device of claim 17, wherein the stimulation waveform also includes a period of no recharge following the passive recharge.
